PTGS2 and urinary bladder cancer: As shown, gemcitabine treatment of human T24 (Supplementary Fig. 5a) and murine G69 (Fig. 3a and Supplementary Fig. 5b) bladder cancer cells in vitro resulted in increased COX-2 expression, as well as significant PGE2 release into cultured media.